Learning Curve for In-Hospital Mortality of Transcatheter Aortic Valve Replacement: Insights from the Brazilian National Registry
Fernando Luiz de Melo Bernardi,Alexandre A Abizaid,Fábio Sândoli de Brito Jr,Pedro A Lemos,Dimytri Alexandre Alvim de Siqueira,Ricardo Alves Costa,Rogério Eduardo Gomes Sarmento Leite,Fernanda Marinho Mangione,Luiz Eduardo Koenig São Thiago,José A Mangione,Valter Correia de Lima,Adriano Dourado Oliveira,Marcos Antônio Marino,Carlos José Francisco Cardoso,Paulo R A Caramori,Rogério Tumelero,Antenor Lages Fortes Portela,Mauricio Prudente,Leônidas Alvarenga Henriques,Fabio Solano Souza,Cristiano Guedes Bezerra,Guy F A Prado Jr,Leandro Zacaris Figueiredo Freitas,Ederlon Ferreira Nogueira,George César Ximenes Meireles,Renato Bastos Pope,Enio Guerios,Pedro Beraldo de Andrade,Luciano de Moura Santos,Mauricio Felippi de Sá Marchi,Nelson Henrique Fantin Fundão,Henrique Barbosa Ribeiro
DOI: https://doi.org/10.36660/abc.20230622
Abstract:Background: Robust data on the learning curve (LC) of transcatheter aortic valve replacement (TAVR) are lacking in developing countries. Objective: To assess TAVR's LC in Brazil over time. Methods: We analyzed data from the Brazilian TAVR registry from 2008 to 2023. Patients from each center were numbered chronologically in case sequence numbers (CSNs). LC was performed using restricted cubic splines adjusted for EuroSCORE-II and the use of new-generation prostheses. Also, in-hospital outcomes were compared between groups defined according to the level of experience based on the CSN: 1st to 40th (initial-experience), 41st to 80th (early-experience), 81st to 120th (intermediate-experience), and over 121st (high-experience). Additional analysis was performed grouping hospitals according to the number of cases treated before 2014 (>40 and ≤40 procedures). The level of significance adopted was <0.05. Results: A total of 3,194 patients from 25 centers were included. Mean age and EuroSCORE II were 80.7±8.1 years and 7±7.1, respectively. LC analysis demonstrated a drop in adjusted in-hospital mortality after treating 40 patients. A leveling off of the curve was observed after case #118. In-hospital mortality across the groups was 8.6%, 7.7%, 5.9%, and 3.7% for initial-, early-, intermediate-, and high-experience, respectively (p<0.001). High experience independently predicted lower mortality (OR 0.57, p=0.013 vs. initial experience). Low-volume centers before 2014 showed no significant decrease in the likelihood of death with gained experience, whereas high-volume centers had a continuous improvement after case #10. Conclusion: A TAVR LC phenomenon was observed for in-hospital mortality in Brazil. This effect was more pronounced in centers that treated their first 40 cases before 2014 than those that reached this milestone after 2014.